Share

Juno Therapeutics CEO Bishop on Immunotherapy

Share This:

Jan.09 — Juno Therapeutics CEO Hans Bishop discusses the company’s immunotherapy for cancer. He speaks with Erik Schatzker on “Bloomberg Technology” from the JPMorgan Healthcare Conference.

Leave a Comment